X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/02/14/2829038/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Vepdegestrant-in-Patients-with-Advanced-Breast-Cancer.html
https://www.globenewswire.com//news-release/2023/12/15/2797014/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2b-Clinical-Trial-of-Samuraciclib-in-Combination-with-Fulvestrant-in-Patients-with-Advanced-HR-HER2-Breast-Cancer.html
https://www.globenewswire.com//news-release/2023/10/18/2762408/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Elacestrant-in-Patients-with-Advanced-Breast-Cancer.html
https://www.globenewswire.com//news-release/2023/09/07/2739242/0/en/Carrick-Therapeutics-Announces-U-S-FDA-Clearance-of-IND-for-CT7439-a-First-In-Class-Inhibitor-of-CDK12-13.html
https://www.globenewswire.com/news-release/2023/07/06/2700384/0/en/Carrick-Therapeutics-Announces-Clinical-Trial-Collaboration-with-Arvinas-and-Pfizer-to-Evaluate-Samuraciclib-and-Vepdegestrant-Combination.html
https://www.clinicaltrialsarena.com/news/carrick-therapeutics-menarini-breast-cancer/
https://www.clinicaltrialsarena.com/news/carrick-therapeutics-menarini-breast-cancer/
https://endpts.com/pfizer-backs-60m-infusion-into-carrick-teams-up-on-breast-cancer-treatment/
https://www.globenewswire.com//news-release/2022/12/01/2565933/0/en/Carrick-Therapeutics-Closes-Series-C-Financing.html
https://www.globenewswire.com//news-release/2022/12/01/2565908/0/en/Carrick-Therapeutics-Announces-35-Million-Investment-from-Pfizer.html
Market Place
Share 
